Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study

BACKGROUND: There are few clinical trials that assess the efficacy of antihistamines in very young children. Rupatadine is a second-generation antihistamine indicated for the treatment of allergic rhinitis (AR) and urticaria. In this study, AR symptoms were evaluated before and after daily 1 mg/mL r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Asthma Allergy
Autores principales: Santamaría, Eva, Izquierdo, Iñaki, Valle, Marta, Vermeulen, Jan, Potter, Paul
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6128281/
https://ncbi.nlm.nih.gov/pubmed/30214250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S164632
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares